Search Results - "Roozendaal, C."

Perioperative platelet reactivity over time in patients undergoing vascular surgery: An observational pilot study by Brand Kanters, A R T, Roozendaal, N C, Parr, N M J, Pasterkamp, G, Urbanus, R T, Korporaal, S J A, de Borst, Gert J

“…Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT…”
Get full text

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands by van Zanten, A, Arends, S, Roozendaal, C, Limburg, P C, Maas, F, Trouw, L A, Toes, R E M, Huizinga, T W J, Bootsma, H, Brouwer, E

“…To determine the prevalence of anticitrullinated protein antibodies (ACPAs) and their association with known rheumatoid arthritis (RA) risk factors in the…”
Get more information

Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus by Henning, S, Westra, J, Roozendaal, C, Haarsma-de Boer, G, Fierro, J J, Horvath, B, Bootsma, H, de Leeuw, K

“…Immunoglobulin G (IgG) autoantibodies in systemic lupus erythematosus (SLE) are considered pathogenic, whereas immunoglobulin M (IgM) autoantibodies may have…”
Get full text

Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq by Koster, R., Brandão, R. D., Tserpelis, D., van Roozendaal, C. E. P., van Oosterhoud, C. N., Claes, K. B. M., Paulussen, A. D. C., Sinnema, M., Vreeburg, M., van der Schoot, V., Stumpel, C. T. R. M., Broen, M. P. G., Spruijt, L., Jongmans, M. C. J., Lesnik Oberstein, S. A. J., Plomp, A. S., Misra-Isrie, M., Duijkers, F. A., Louwers, M. J., Szklarczyk, R., Derks, K. W. J., Brunner, H. G., van den Wijngaard, A., van Geel, M., Blok, M. J.

“…Neurofibromatosis type 1 (NF1) is caused by loss-of-function variants in the NF1 gene. Approximately 10% of these variants affect RNA splicing and are either…”
Get full text

Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history by Bonarius, H P J, Brandsma, C A, Kerstjens, H A M, Koerts, J A, Kerkhof, M, Nizankowska-Mogilnicka, E, Roozendaal, C, Postma, D S, Timens, W

“…Chronic obstructive pulmonary disease (COPD) is associated with a higher prevalence of antinuclear autoantibodies (ANAs). However, a significant subgroup of…”
Get more information

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies? by Kamburova, E. G., Wisse, B. W., Joosten, I., Allebes, W. A., van der Meer, A., Hilbrands, L. B., Baas, M. C., Spierings, E., Hack, C. E., van Reekum, F. E., van Zuilen, A. D., Verhaar, M., Bots, M. L., Drop, A. C. A. D., Plaisier, L., Seelen, M. A. J., Sanders, J. S. F., Hepkema, B. G., Lambeck, A. J., Bungener, L. B., Roozendaal, C., Tilanus, M. G. J., Vanderlocht, J., Voorter, C. E., Wieten, L., van Duijnhoven, E. M., Gelens, M., Christiaans, M. H. L., van Ittersum, F. J., Nurmohamed, A., Lardy, N. M., Swelsen, W., van der Pant, K. A., van der Weerd, N. C., ten Berge, I. J. M., Bemelman, F. J., Hoitsma, A., van der Boog, P. J. M., de Fijter, J. W., Betjes, M. G. H., Heidt, S., Roelen, D. L., Claas, F. H., Otten, H. G.

“…Solid‐phase multiplex‐bead assays are widely used in transplantation to detect anti‐human leukocyte antigen (HLA) antibodies. These assays enable high…”
Get full text

The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis by ARENDS, S, LEBBINK, H. R, WOLBINK, G. J, BROUWER, E, SPOORENBERG, A, BUNGENER, L. B, ROOZENDAAL, C, VAN DER VEER, E, HOUTMAN, P. M, GRIEP, E. N, LIMBURG, P. C, KALLENBERG, C. G. M

“…To investigate the influence of antibody formation to TNF-α blocking agents on the clinical response in AS patients treated with infliximab (IFX), etanercept…”
Get full text

Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection by van Harssel, J. J. T., van Roozendaal, C. E. P., Detisch, Y., Brandão, R. D., Paulussen, A. D. C., Zeegers, M., Blok, M. J., Gómez García, E. B.

“…Considerable differences exist amongst countries in the mutation probability methods and thresholds used to select patients for BRCA1/2 genetic screening. In…”
Get full text

Are anti‐neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? by ROOZENDAAL, C, KALLENBERG, C. G. M

“…Since the first detection of ANCA in IBD, numerous studies have dealt with their prevalence, antigenic specificities, clinical significance, pathophysiological…”
Get full text

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 by Osorio, A, Milne, R L, Alonso, R, Pita, G, Peterlongo, P, Teulé, A, Nathanson, K L, Domchek, S M, Rebbeck, T, Lasa, A, Konstantopoulou, I, Hogervorst, F B, Verhoef, S, van Dooren, M F, Jager, A, Ausems, M G E M, Aalfs, C M, van Asperen, C J, Vreeswijk, M, Waisfisz, Q, Van Roozendaal, C E, Ligtenberg, M J, Easton, D F, Peock, S, Cook, M, Oliver, C T, Frost, D, Curzon, B, Evans, D G, Lalloo, F, Eeles, R, Izatt, L, Davidson, R, Adlard, J, Eccles, D, Ong, K-r, Douglas, F, Downing, S, Brewer, C, Walker, L, Nevanlinna, H, Aittomäki, K, Couch, F J, Fredericksen, Z, Lindor, N M, Godwin, A, Isaacs, C, Caligo, M A, Loman, N, Jernström, H, Barbany-Bustinza, G, Liljegren, A, Ehrencrona, H, Stenmark-Askmalm, M, Feliubadaló, L, Manoukian, S, Peissel, B, Zaffaroni, D, Bonanni, B, Fortuzzi, S, Johannsson, O T, Chenevix-Trench, G, Chen, X-C, Beesley, J, Spurdle, A B, Sinilnikova, O M, Healey, S, McGuffog, L, Antoniou, A C, Brunet, J, Radice, P, Benítez, J

“…Background: Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of…”
Get full text

The PROCARE consortium: Towards an improved allocation strategy for kidney allografts by Otten, H.G, Spierings, E, Hack, C.E, van Reekum, F, van Zuilen, A.D, Verhaar, M.C, Bots, M.L, Claas, F.H.J, Roelen, D.L, de Fijter, J.W, Betjes, M.G.H, Seelen, M.A.J, Sanders, J.S.F, Hepkema, B.G, Lambeck, A.J, Bungener, L.B, Roozendaal, C, Tilanus, M.G.J, Vanderlocht, J, Voorter, C.E, Wieten, L, Christiaans, M, Hilbrands, L.B, Baas, M, Joosten, I, Allebes, W.A, van der Meer, A, van Ittersum, F, Nurmohamed, A, Lardy, N.M, Swelsen, W.T, van Donselaar - van der Pant, K.A.M.I, van der Weerd, N.C, ten Berge, R.J.M, Bemelman, F.J, Hoitsma, A.J

Get full text

Patient experience and satisfaction with admission to an acute geriatric community hospital in the Netherlands: a mixed method study by Ribbink, Marthe E, Roozendaal, Catharina C, MacNeil-Vroomen, Janet L, Franssen, Remco, Buurman, Bianca M

“…PurposeThe acute geriatric community hospital (AGCH) in an intermediate care facility is an alternative to conventional hospitalization. A comprehensive…”
Get full text

Medical adjunctive therapy for patients with chronic limb-threatening ischemia: a systematic review by Ipema, Jetty, Roozendaal, Nicolaas C, Bax, Willem A, de Borst, Gert J, de Vries, Jean Paul P M, Ünlü, Çağdaş

“…The aim of this article is to systematically review the literature on medical adjunctive therapy for patients with chronic limb-threatening ischemia (CLTI)…”
Get full text

Catalase and α‐enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD) by ROOZENDAAL, C, ZHAO, M. H, HORST, G, LOCKWOOD, C. M, KLEIBEUKER, J. H, LIMBURG, P. C, NELIS, G. F, KALLENBERG, C. G

“…In IBD, the target antigens of anti‐neutrophil cytoplasmic autoantibodies (ANCA) have not been fully identified, which limits the analysis of the diagnostic…”
Get full text

Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures by van Roozendaal, C.E.P, Gillis, A.J.M, Klijn, J.G.M, van Ooijen, B, Claassen, C.J.C, Eggermont, A.M.M, Henzen-Logmans, S.C, Oosterhuis, J.W, Foekens, J.A, Looijenga, L.H.J

“…Insulin-like growth factors are involved in the paracrine growth regulation of human breast tumor cells. IGF2 is imprinted in most tissues, and shows…”
Get full text

Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases by Roozendaal, C, Kallenberg, C G

“…Anti-neutrophil cytoplasm antibodies (ANCA) are autoantibodies directed against cytoplasmic constituents of neutrophil granulocytes and monocytes. ANCA have…”
Get more information

Stromal influences on breast cancer cell growth by VAN ROOZENDAAL, C. E. P, VAN OOIJEN, B, KLIJN, J. G. M, CLAASSEN, C, EGGERMONT, A. M. M, HENZEN-LOGMANS, S. C, FOEKENS, J. A

“…Paracrine influences from fibroblasts derived from different sources of breast tissue on epithelial breast cancer cell growth in vitro were investigated…”
Get full text

DOP25 Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis by Mendieta Escalante, E A, Parada-Venegas, D, Roozendaal, C, Hermoso, M, Bourgonje, A R, Faber, K N, Gerard, D

“…Abstract Background Antibodies against Neutrophil Extracellular Traps (ANETAs) have emerged as markers in multiple autoimmune disorders (i.e. rheumatoid…”
Get full text

Does Analysis of the Antigenic Specificities of Anti-Neutrophil Cytoplasmic Antibodies Contribute to Their Clinical Significance in the Inflammatory Bowel Diseases? by ROOZENDAAL, C, POGANY, K, HORST, G, JAGT, T. G, KLEIBEUKER, J. H, NELIS, G. F, LIMBURG, P. C, KALLENBERG, C. G. M

“…Background: The clinical relevance of anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel diseases is unclear. Definition of their antigenic…”
Get full text

P100 Atypical Anti-Neutrophil Cytoplasmatic Antibodies Are Antibodies Against Neutrophil Extracellular Traps: A Novel Pathophysiological Mechanism In Ulcerative Colitis by Mendieta Escalante, E A, Parada-Venegas, D, Bourgonje, A, Roozendaal, C, Hermoso Ramello, M, Faber, K N, Dijkstra, G

“…Abstract Background The number of mucosal neutrophils, as well as the presence of neutrophil extracellular traps (NETs), correlate with disease activity in…”
Get full text